Actualités

OCR and Biofortis discuss the importance of the microbiome, especially in the field of oncology, in an interview with Dr Tierny and Dr Rybicka

OCR together with ImmunXperts and Rarecells win k€520 funding in Eureka Eurostars program to initiate €1,3m “ICOM” platform for preclinical and clinical human cancer drug evaluation in pet dog’s model

OCR, the company revolutionising the selection of effective drug candidates for cancer, raises €1.25m from Newfund, NFA and the management team in order to accelerate its growth

OCR and Pierre Fabre’s Phase I Clinical Pharmacology Study published in prestigious Clinical Cancer Research journal

OCR and Ecrins Therapeutics initiate €1.9m “Dog to Man” pioneering translational research programme to advance human and vet oncology treatment

OCR and PRISM announce ground-breaking research collaboration to advance real-time diagnosis using mass spectrometry 20

OCR strengthens veterinary and R&D expertise to respond to the needs of the pharmaceutical industry

Scroll to Top